Literature DB >> 14766810

Antigen capture competitive enzyme-linked immunosorbent assays using baculovirus-expressed antigens for diagnosis of bluetongue virus and epizootic hemorrhagic disease virus.

J O Mecham1, W C Wilson.   

Abstract

Bluetongue virus (BTV) and epizootic hemorrhagic disease virus (EHDV) are orbiviruses that infect both livestock and wild ruminants. Antigenic cross-reactivity between BTV and EHDV often results in serologic misdiagnosis. Competitive enzyme-linked immunosorbent assays (c-ELISAs) show increased sensitivity and specificity for the identification of these viral diseases; however, the preparation of cell culture-derived viral antigen for these tests is laborious and variable from batch to batch, and the resulting antigen may be infectious. To overcome these problems, the genes coding for a structural protein, VP7, of BTV and EHDV were cloned into baculovirus and the recombinant proteins were expressed in Sf9 cultured insect cells. Recombinant viral proteins released into the baculovirus-infected Sf9 cell culture supernatant were used in antigen capture c-ELISAs (Ag Cap c-ELISA) tests that specifically detected antibody in the serum of cattle experimentally infected with BTV and EHDV. The diagnostic utility of the Ag Cap c-ELISA was demonstrated by comparison with a commercial c-ELISA. The Ag Cap c-ELISA offers the advantages of using an easily produced, easily standardized, noninfectious antigen that does not require further purification or concentration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14766810      PMCID: PMC344499          DOI: 10.1128/JCM.42.2.518-523.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  High level expression of the major core protein VP7 and the non-structural protein NS3 of bluetongue virus in yeast: use of expressed VP7 as a diagnostic, group-reactive antigen in a blocking ELISA.

Authors:  J C Martyn; A R Gould; B T Eaton
Journal:  Virus Res       Date:  1991-03       Impact factor: 3.303

2.  Monoclonal antibody based competitive ELISA for the detection of antibodies against epizootic haemorrhagic disease of deer virus.

Authors:  J A Thevasagayam; T R Woolhouse; P P Mertens; J N Burroughs; J Anderson
Journal:  J Virol Methods       Date:  1996-04-05       Impact factor: 2.014

3.  Competitive ELISA for the detection of antibodies against epizootic haemorrhagic disease of deer virus.

Authors:  J A Thevasagayam; P P Mertens; J N Burroughs; J Anderson
Journal:  J Virol Methods       Date:  1995-11       Impact factor: 2.014

4.  Characterisation of monoclonal antibodies to epizootic hemorrhagic disease virus of deer (EHDV) and bluetongue virus by immunisation of mice with EHDV recombinant VP7 antigen.

Authors:  E Zhou; A Afshar
Journal:  Res Vet Sci       Date:  1999-06       Impact factor: 2.534

5.  A competitive ELISA for detection of antibodies to the group antigen of bluetongue virus.

Authors:  J J Reddington; G M Reddington; N J MacLachlan
Journal:  J Vet Diagn Invest       Date:  1991-04       Impact factor: 1.279

6.  Expression of the major inner capsid protein of the epizootic haemorrhagic disease virus in baculovirus and potential diagnostic use.

Authors:  H S Nagesha; A R Gould; J R White; R A Lunt; C J Duch
Journal:  Virus Res       Date:  1996-08       Impact factor: 3.303

7.  Vaccinia virus expression of the VP7 protein of South African bluetongue virus serotype 4 and its use as an antigen in a capture ELISA.

Authors:  M Cloete; D H du Plessis; A A van Dijk; H Huismans; G J Viljoen
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  Competitive ELISA for serodiagnosis of bluetongue: evaluation of group-specific monoclonal antibodies and expressed VP7 antigen.

Authors:  A Afshar; B T Eaton; P F Wright; J E Pearson; J Anderson; M Jeggo; H C Trotter
Journal:  J Vet Diagn Invest       Date:  1992-07       Impact factor: 1.279

9.  Detection of bluetongue virus from blood of infected sheep by use of an antigen-capture enzyme-linked immunosorbent assay after amplification of the virus in cell culture.

Authors:  J O Mecham
Journal:  Am J Vet Res       Date:  1993-03       Impact factor: 1.156

10.  Development and evaluation of an enzyme-linked immunosorbent assay for detection of bovine antibodies to epizootic hemorrhagic disease of deer viruses.

Authors:  A Afshar; P F Wright; L A Taylor; J L Shapiro; G C Dulac
Journal:  Can J Vet Res       Date:  1992-04       Impact factor: 1.310

View more
  10 in total

1.  Purification, stability, and immunogenicity analyses of five bluetongue virus proteins for use in development of a subunit vaccine that allows differentiation of infected from vaccinated animals.

Authors:  Jenna Anderson; Emmanuel Bréard; Karin Lövgren Bengtsson; Kjell-Olov Grönvik; Stéphan Zientara; Jean-Francois Valarcher; Sara Hägglund
Journal:  Clin Vaccine Immunol       Date:  2014-01-22

2.  Production of a recombinant major inner capsid protein for serological detection of epizootic hemorrhagic disease virus.

Authors:  Lizhong Luo; Marta I Sabara
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

3.  An updated review on bluetongue virus: epidemiology, pathobiology, and advances in diagnosis and control with special reference to India.

Authors:  Mani Saminathan; Karam Pal Singh; Jaynudin Hajibhai Khorajiya; Murali Dinesh; Sobharani Vineetha; Madhulina Maity; At Faslu Rahman; Jyoti Misri; Yashpal Singh Malik; Vivek Kumar Gupta; Raj Kumar Singh; Kuldeep Dhama
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

4.  Animal viral diseases and global change: bluetongue and West Nile fever as paradigms.

Authors:  Miguel Á Jiménez-Clavero
Journal:  Front Genet       Date:  2012-06-13       Impact factor: 4.599

5.  Kinetic ELISA in microfluidic channels.

Authors:  Naoki Yanagisawa; Debashis Dutta
Journal:  Biosensors (Basel)       Date:  2011-06-17

6.  Evaluation of A Baculovirus-Expressed VP2 Subunit Vaccine for the Protection of White-Tailed Deer (Odocoileus virginianus) from Epizootic Hemorrhagic Disease.

Authors:  Sun Young Sunwoo; Leela E Noronha; Igor Morozov; Jessie D Trujillo; In Joong Kim; Erin E Schirtzinger; Bonto Faburay; Barbara S Drolet; Kinga Urbaniak; D Scott McVey; David A Meekins; Mitchell V Palmer; Velmurugan Balaraman; William C Wilson; Juergen A Richt
Journal:  Vaccines (Basel)       Date:  2020-01-31

7.  Development of a Competitive Enzyme-Linked Immunosorbent Assay Based on Purified Recombinant Viral Protein 7 for Serological Diagnosis of Epizootic Haemorrhagic Disease in Camels.

Authors:  Anna Serroni; Simonetta Ulisse; Mariangela Iorio; Caterina Laguardia; Lilia Testa; Gisella Armillotta; Marco Caporale; Romolo Salini; Davide Lelli; Ulrich Wernery; Rekha Raghavan; Maria Teresa Mercante; Mauro Di Ventura
Journal:  J Trop Med       Date:  2022-03-21

8.  Generation of a Soluble African Horse Sickness Virus VP7 Protein Capable of Forming Core-like Particles.

Authors:  Shani Bekker; Henk Huismans; Vida van Staden
Journal:  Viruses       Date:  2022-07-26       Impact factor: 5.818

9.  A comprehensive study on seroprevalence of bluetongue virus in Haryana state of India.

Authors:  Sushila Maan; Anuj Tiwari; Deepika Chaudhary; Anita Dalal; Nitish Bansal; Vinay Kumar; Kanisht Batra; Aman Kumar; Naresh Kumar Kakker; Narender Singh Maan
Journal:  Vet World       Date:  2017-12-13

10.  Development and Validation of an ELISA for the Detection of Bluetongue Virus Serotype 4-Specific Antibodies.

Authors:  Emmanuel Bréard; Mathilde Turpaud; Georges Beaud; Lydie Postic; Aurore Fablet; Martin Beer; Corinne Sailleau; Grégory Caignard; Cyril Viarouge; Bernd Hoffmann; Damien Vitour; Stéphan Zientara
Journal:  Viruses       Date:  2021-08-31       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.